Incorrect Affiliation
In the published article, there was an error in affiliation 1. Instead of “Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China,” it should be deleted.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
gastrointestinal stromal tumor, R1 margin, Imatinib, prognosis, meta-analysis
Citation
Liu Z, Zhang Y, Yin H, Geng X, Li S, Zhao J, Zeng Z, Ye X, Yu J, Feng F and Kang W (2023) Corrigendum: Comparison of prognosis between microscopically positive and negative surgical margins for primary gastrointestinal stromal tumors: A systematic review and meta-analysis. Front. Oncol. 12:1110168. doi: 10.3389/fonc.2022.1110168
Received
28 November 2022
Accepted
29 November 2022
Published
23 January 2023
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
12 - 2022
Updates
Copyright
© 2023 Liu, Zhang, Yin, Geng, Li, Zhao, Zeng, Ye, Yu, Feng and Kang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Weiming Kang, kangweiming@163.com; Fan Feng, surgeonfengfan@163.com
This article was submitted to Surgical Oncology, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.